Lataa...
Adoptive Therapy with Chimeric Antigen Receptor Modified T Cells of Defined Subset Composition
The ability to engineer T cells to recognize tumor cells through genetic modification with a synthetic chimeric antigen receptor has ushered in a new era in cancer immunotherapy. The most advanced clinical applications are in in targeting CD19 on B cell malignancies. The clinical trials of CD19 CAR...
Tallennettuna:
| Päätekijät: | , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4149222/ https://ncbi.nlm.nih.gov/pubmed/24667960 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0000000000000036 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|